Name: Orion as an Investment | Life Science Night Dec. 9, 2025
Uploaded: 2025-12-09T21:10:50.367Z
Description: Tuukka Hirvonen, Head of Investor Relations, talks about pharmaceutical company Orion as an investment.

videoSlug

VideoSlug_VideoQuery

slug

VideoPageContentQuery

content

videos

query VideoSlug_VideoQuery(
  $videoSlug: String!
) {
  ...VideoPageContentQuery_1X4EH4
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  createdAt
  changedAt
  isPremium
  authors {
    __typename
    name
    pageUrl
    id
  }
  companies {
    name
    pageUrl
    id
  }
  tags {
    name
    id
  }
  ... on Video {
    liveTime
    videoUrl
    videoEmbedUrl(location: "inderes")
  }
  ... on Webcast {
    liveTime
    videoUrl
    videoEmbedUrl(location: "inderes")
  }
}

fragment LatestVideos_Videos on Query {
  videos(first: 5, upcoming: false, order: {field: liveTime, direction: DESC}) {
    edges {
      node {
        id
        title
        lang
        pageUrl
        liveTime
        isLive
        companies {
          name
          squareLogoUrl
          id
        }
      }
    }
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment VideoPageContentQuery_1X4EH4 on Query {
  content(slug: $videoSlug, type: [VIDEO, WEBCAST]) {
    __typename
    id
    title
    slug
    lang
    htmlBody
    isPremium
    summary
    companies {
      viewerIsFollowing
      id
      name
      pageUrl
      defaultInstrument {
        id
        isin
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    createdAt
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    ... on Video {
      imgUrl
      videoEmbedUrl(location: "inderes")
      audioEmbedUrl
      registrationInfoHtml
      registrationUrl
      liveTime
      transcript {
        segments {
          speakerId
          speakerName
          sentences {
            start
            end
            text
          }
        }
        speakers {
          speakerId
          name
        }
      }
    }
    ... on Webcast {
      imgUrl
      videoEmbedUrl(location: "inderes")
      registrationInfoHtml
      registrationUrl
      liveTime
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
  }
  ...LatestVideos_Videos
}


type

__typename

title

lang

htmlBody

isPremium

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

changedAt

first

order

upcoming

edges

Orion

Tuukka Hirvonen, Head of Investor Relations, talks about pharmaceutical company Orion as an investment.

Tuukka Hirvonen, Head of Investor Relations, talks about pharmaceutical company Orion as an investment.
Orion&#x2019;s products are sold globally in over one hundred countries through Orion&#x2019;s own sales network and by partners.
 Life Science Night 2025
<ul>
<li>Keynote &#x2013; Antti Siltanen, Inderes (<a href="https://www.inderes.fi/videos/life-science-companies-as-investments-or-life-science-night-dec-9-2025">link</a>)</li>
<li>Orion Pharma &#x2013; Tuukka Hirvonen, Head of Investor Relations (<a href="https://www.inderes.fi/videos/orion-as-an-investment-or-life-science-night-dec-9-2025">link</a>)</li>
<li>Aiforia &#x2013; Jukka Tapaninen, CEO (<a href="https://www.inderes.fi/videos/aiforia-as-an-investment-or-life-science-night-dec-9-2025">link</a>)</li>
<li>Herantis Pharma &#x2013; Antti Vuolanto, CEO (<a href="https://www.inderes.fi/videos/herantis-pharma-as-an-investment-or-life-science-night-dec-9-2025">link</a>)</li>
</ul>
 Life Science Night December 9, 2025 (<a href="https://www.inderes.fi/videos/life-science-night-or-december-9-2025">link</a>) Life Science Night December 2, 2024 (<a href="https://www.inderes.fi/videos/life-science-night-or-december-2-2024">link</a>)

Inderes

Orion as an Investment | Life Science Night Dec. 9, 2025

Clas Ohlson

Clas Ohlson AB, CMD

BioMar Group

Michael Friis taler med Carlos Diaz, CEO i BioMar

Presentation of BioMar

Novo Nordisk

Genmab

Danish Aerospace & Defence Company

Hafnia

FLSmidth & Co.

Swiss Properties Invest

Rockwool

Ambu

Bavarian Nordic

HCA Morgenbørs 03/06 - Overvejende negative markeder og fokus på Genmab og Novo Nordisk

Clas Ohlson, Audiocast, Q4'25

Orion as an Investment | Life Science Night Dec. 9, 2025

Stay up to date

Upcoming webcasts

Orion as an Investment | Life Science Night Dec. 9, 2025

Stay up to date

Recent videos

Upcoming webcasts

Recent videos